NAN FUNG TRINITY (HK) LTD
Long book
$910.6M
Q1 2026
Positions
62
Top-10 weight
40%
concentration
Last quarter
+16.7%
SPY +14.8%
Turnover
29%
of book per quarter
Strategy in plain words
auto-generated from filingsNAN FUNG TRINITY (HK) LTD is a concentrated fundamental stock-picker, running a $910.6M US long book across 62 positions.
The portfolio is moderately concentrated (top 10 ≈ 40% of the book). The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: AMCOR PLC, PPG INDUSTRIES INC, KT CORP-SP ADR, NVIDIA CORP, ISHARES MSCI THAILAND ETF.
Over the last 9 quarters its long book ran on average 1.3pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-2.3%
Q2 2024
+17.1%
Q3 2024
-9.0%
Q4 2024
+6.6%
Q1 2025
+9.2%
Q2 2025
+10.2%
Q3 2025
+3.2%
Q4 2025
+0.1%
Q1 2026
+16.7%
Sector allocation
Healthcare 33%
Technology 23%
Other 16%
Materials 7%
Consumer discretionary 6%
Industrials 6%
Financials 5%
Communications 3%
Long book by quarter
What does NAN FUNG own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| AMCR AMCOR PLC | Other | 1.1M | $44.4M | 4.9% | New |
| PPG PPG INDUSTRIES INC | Other | 397.3K | $42.5M | 4.7% | +47.4% |
| NVDA NVIDIA CORP | Technology | 230.1K | $40.1M | 4.4% | +18.2% |
| AMD ADVANCED MICRO DEVICES | Technology | 161.7K | $32.9M | 3.6% | Held |
| UNH UNITEDHEALTH GROUP INC | Financials | 104.2K | $28.2M | 3.1% | +98.6% |
| APD AIR PRODUCTS & CHEMICALS INC | Materials | 96.7K | $28.1M | 3.1% | Held |
| HD HOME DEPOT INC | Consumer discretionary | 72.7K | $23.9M | 2.6% | +54.9% |
| MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 232.7K | $21.5M | 2.4% | +2.3% |
| HON HONEYWELL INTERNATIONAL INC | Industrials | 83.9K | $19.0M | 2.1% | Held |
| DHR DANAHER CORP | Technology | 98.6K | $18.7M | 2.1% | Held |
| PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 160.7K | $16.9M | 1.9% | -11.1% |
| BBIO BRIDGEBIO PHARMA INC | Healthcare | 219.2K | $16.3M | 1.8% | +99.1% |
| WBD WARNER BROS DISCOVERY INC | Communications | 575.7K | $15.8M | 1.7% | +15.8% |
| IMNM IMMUNOME INC | Healthcare | 714.6K | $15.6M | 1.7% | Held |
| GEHC GE HEALTHCARE TECHNOLOGY | Healthcare | 211.0K | $15.0M | 1.6% | -31.7% |
| OC OWENS CORNING | Industrials | 136.0K | $14.7M | 1.6% | New |
| XENE XENON PHARMACEUTICALS INC | Healthcare | 247.8K | $14.4M | 1.6% | +9.2% |
| SRRK SCHOLAR ROCK HOLDING CORP | Healthcare | 285.5K | $14.0M | 1.5% | +8.5% |
| MP MP MATERIALS CORP | Materials | 283.1K | $13.7M | 1.5% | Held |
| TRVI TREVI THERAPEUTICS INC | Healthcare | 1.1M | $13.6M | 1.5% | +24.6% |
| PINS PINTEREST INC- CLASS A | Technology | 658.7K | $12.1M | 1.3% | New |
| CELC CELCUITY INC | Healthcare | 103.8K | $11.8M | 1.3% | +28.5% |
| TGT TARGET CORP | Consumer discretionary | 96.8K | $11.7M | 1.3% | +10.9% |
| MCHP MICROCHIP TECHNOLOGY INC | Technology | 170.6K | $11.0M | 1.2% | New |
| SVRA SAVARA INC | Healthcare | 1.8M | $10.1M | 1.1% | +9.1% |
| ORCL ORACLE CORP | Technology | 65.6K | $9.7M | 1.1% | Held |
| META META PLATFORMS INC-CLASS A | Technology | 15.2K | $8.7M | 1.0% | Held |
| KURA KURA ONCOLOGY INC | Healthcare | 1.1M | $8.7M | 1.0% | +10.4% |
| BCAX BICARA THERAPEUTICS INC | Healthcare | 427.9K | $8.5M | 0.9% | +14.9% |
| PCVX VAXCYTE INC | Healthcare | 122.9K | $7.1M | 0.8% | -14.0% |
| ABEO ABEONA THERAPEUTICS INC | Healthcare | 956.8K | $4.3M | 0.5% | Held |
| SLNOEUR SOLENO THERAPEUTICS INC | — | 126.0K | $4.2M | 0.5% | +1.8% |
| 4XC1 KALVISTA PHARMACEUTICALS INC | — | 154.5K | $3.1M | 0.3% | Held |
| CLYM CLIMB BIO INC | Healthcare | 420.5K | $2.9M | 0.3% | -9.3% |
| AVTX AVALO THERAPEUTICS INC | Healthcare | 189.0K | $2.8M | 0.3% | Held |
| GERN GERON CORP | Healthcare | 1.4M | $2.0M | 0.2% | Held |
| QURE UNIQURE NV | Healthcare | 115.5K | $1.9M | 0.2% | Held |
| REPL REPLIMUNE GROUP INC | Healthcare | 196.3K | $1.5M | 0.2% | -65.9% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 5, 2026 | 62 | $910.6M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 4, 2026 | 78 | $1.26B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 4, 2025 | 71 | $1.00B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 8, 2025 | 59 | $835.8M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 8, 2025 | 39 | $630.5M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 4, 2025 | 30 | $489.7M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 13, 2024 | 26 | $528.4M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 2, 2024 | 25 | $463.9M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 9, 2024 | 27 | $439.6M | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP